Pharmaceuticals

Huoxiang Zhengqi For Covid 19 Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

June 11, 2025 by Marketing Posting

We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

#What is the Anticipated CAGR of the Huoxiang Zhengqi For Covid 19 Market, and What Factors Will Drive It?#_x000D_

The market for huoxiang zhengqi for COVID-19 has seen an impressive boost in recent years. The industry, valued at $1.38 billion in 2024, is projected to expand to $1.55 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.8%. This growth over the years can be linked to factors such as heightened demand for traditional Chinese medicaments, increased public consciousness about natural cure options, a surge in cases of gastrointestinal issues, heightened demand for products that enhance immunity, and a surge in COVID-19 cases._x000D_

_x000D_

In the coming years, the market size for huoxiang zhengqi in the treatment of COVID-19 is anticipated to witness rapid expansion, reaching a valuation of $2.48 billion in 2029, with an impressive Compound Annual Growth Rate (CAGR) of 12.4%. This growth during the forecast period can be ascribed to factors such as the growing popularity of supplements promoting immune health, the emerging trend of self-care for minor health issues, the soaring demand for non-pharmaceutical approaches, the enhanced access to traditional Chinese medicine products over the internet, and the increasing need for personalized healthcare solutions. The forecast period will also see major trends including remote diagnosis aided by technology, the creation of new dosage forms, the development of synergistic formulations, the amalgamation into telehealth platforms, and adherence to hospital guidelines for COVID-19 treatment._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24246&type=smp_x000D_

_x000D_

#What External and Internal Drivers Are Contributing to the Growth of the Huoxiang Zhengqi For Covid 19 Market?#_x000D_

The growth of the Huoxiang Zhengqi for COVID-19 market is anticipated to be led by the increasing demand for traditional Chinese medicine. This health system, deeply rooted in ancient practices, harnesses the powers of herbal remedies, acupuncture, massage and dietary therapy to rebalance internal energy, aid recovery and ward off disease. Consumers are progressively more invested in the pursuit of natural and herbal solutions for health issues, eschewing traditional Western medicine in favor of this more holistic approach. Huoxiang Zhengqi for COVID-19 enriches this practice by introducing an integrative method based on herbs known to harmonize the immune response and mitigate symptoms relevant to viral diseases. This conclusion is supported by a report from the US-based National Library of Medicine, published in January 2025, which reveals an export value of traditional Chinese medicine, inclusive of medicinal materials and plant extracts, of a substantial $1.933 billion in 2023. Therefore, the surge in traditional Chinese medicine is indeed driving the expansion of the Huoxiang Zhengqi for COVID-19 market. The Huoxiang Zhengqi for COVID-19 market is also set to benefit from the escalating demand for herbal medicine, as consumer preferences turn more towards natural remedies. Herbal medicine refers to the therapeutic use of plants or plant substances to prevent and manage various health conditions. This growing inclination for herbal medicine over synthetic drugs stems from consumers’ perception of natural remedies as safer, with fewer side effects, and more holistic. Huoxiang Zhengqi for COVID-19 adds value to this trend by supplying a traditional remedy that endorses immune response, eases symptoms, and encourages recovery, supporting the pivotal role of herbal therapies in virus management. A highlight of this trend is evident in the statistics from HerbalGram, a US-based nonprofit organization. The group reports an increase in annual sales of herbal dietary supplements from $12.018 billion in 2022 to $12.551 billion in 2023, reflecting a 4.4% upsurge. Consequently, the flourishing demand for herbal medicine is guiding the growth of the Huoxiang Zhengqi for COVID-19 market._x000D_

_x000D_

#What Segment Types Define the Huoxiang Zhengqi For Covid 19 Market Structure?#_x000D_

The huoxiang zhengqi for covid 19 market covered in this report is segmented –_x000D_

_x000D_

1) By Product Type: Liquid, Pills, Granules, Other Product Types_x000D_

2) By Consumers: Health-Conscious Consumers, Individuals Seeking Immunity Support, Alternative Medicine Enthusiasts, Parents Purchasing For Children_x000D_

3) By Usage Occasions: Preventive Health Use, During COVID 19 Symptoms, Post-Recovery Health Management, Seasonal Illness Protection_x000D_

4) By Application: Hospitals, Clinics, Home Care, Other Applications_x000D_

5) By Distribution Chanel, Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Other Distribution Chanels_x000D_

_x000D_

Subsegments:_x000D_

1) By Liquid: Oral Liquid, Injectable Liquid_x000D_

2) By Pills: Tablets, Capsules_x000D_

3) By Granules: Single-Dose Granules, Multi-Dose Granules_x000D_

4) By Other Product Types: Syrup, Powder For Solution_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24246&type=smp_x000D_

_x000D_

#Which Geographic Areas Hold the Strongest Growth Potential in the Huoxiang Zhengqi For Covid 19 Market?#_x000D_

Asia-Pacific was the largest region in the Huoxiang Zhengqi for COVID-19 market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the huoxiang zhengqi for covid 19 market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/huoxiang-zhengqi-for-covid-19-global-market-report_x000D_

_x000D_

#What Is the Definition of the Huoxiang Zhengqi For Covid 19 Market?#_x000D_

Huoxiang Zhengqi for COVID-19 is a traditional Chinese herbal formula used to treat COVID-19 cases, particularly where symptoms involve gastrointestinal issues such as nausea, diarrhea, or fatigue due to dampness. Its primary purpose in this context is to expel dampness, relieve exterior syndromes, and support digestive and immune function. It is often combined with antiviral and supportive therapies in traditional Chinese medicine protocols._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=24246&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_